AIM

AIM ImmunoTech Inc.

Sağlık

COMPLIANT — All screening ratios are below the thresholds; the company is compliant with halal investment criteria.

$0.15

Price (1 Year)

$1.47 $0.15

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %26 / %30
Non-compliant assets / Total market cap %0.5 / %30
Non-compliant revenue / Total income %0 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's flagship products are Ampligen (rintatolimod), a drug of large macromolecular double-stranded ribonucleic acid molecules to treat chronic fatigue syndrome; and Alferon N Injection (Interferon alfa), a purified, natural-source, glycosylated, multi-species alpha interferon product for the treatment of genital warts.

Website

Analysis (Turkish): AIM Hissesi Caiz mi, Helal mi? AIM ImmunoTech Inc. Katılım Analizi